title: Cellular and molecular aspects of thiamin uptake by human liver cells: studies with cultured HepG2 cells.
abstract: The liver is an important site for thiamin metabolism, utilization, and storage. Little is known about the mechanism of thiamin uptake by the human liver. In this study, we examined cellular and molecular aspects of the human liver thiamin uptake process using the human-derived liver HepG2 cells as a model system. Our studies showed that the initial rate of thiamin uptake to be: (1) Na(+)-independent and occurs with no detectable metabolic alterations in the transported substrate, (2) highly pH-dependent with diminished uptake upon decreasing incubation buffer pH from 8.0 to 5.0, (3) higher following cell acidification compared to unacidified control cells, (4) saturable as a function of concentration with an apparent K(m) of 7.7+/-1.6 microM, (5) inhibited by the thiamin structural analogues oxythiamin and amprolium but not by the unrelated organic cations tetraethylammonium (TEA) and N-methylnicotinamide (NMN), and (6) inhibited in a concentration-dependent manner by the membrane transport inhibitor amiloride. Both of the recently cloned human thiamin transporters, i.e., SLC19A2 and SLC19A3, were found to be expressed in liver HepG2 cells with the former being the predominant form. High promoter activity of the predominant form, i.e., SLC19A2, was detected in HepG2 cells, and the minimal region of the SLC19A2 promoter required for its basal activity in these cells was found to be encoded in a sequence between -356 and -36 and has multiple putative cis-regulatory elements. Mutation of a number of these putative cis-elements diminished promoter activity of the SLC19A2 minimal region. These results show the involvement of a specialized carrier-mediated mechanism for thiamin uptake by human liver HepG2 cells. In addition, SLC19A2 was found to be the predominant thiamin uptake carrier expressed in these cells and its promoter displays a high level of activity in them.
authors.affiliation: Department of Medicine and Physiology, VA Medical Center, Long Beach, CA 90822-5201, USA. hmsaid@uci.edu
authors.forename: Hamid M
authors.initials: HM
authors.lastname: Said
authors.forename: Jack C
authors.initials: JC
authors.lastname: Reidling
authors.forename: Alvaro
authors.initials: A
authors.lastname: Ortiz
mesh_terms: D001483:Base Sequence; D002460:Cell Line; D017931:DNA Primers; D006801:Humans; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D026901:Membrane Transport Proteins / Q000235:genetics; D011401:Promoter Regions, Genetic; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013831:Thiamine / Q000378:metabolism*
chemical_list: D017931:DNA Primers; D026901:Membrane Transport Proteins; C120043:SLC19A2 protein, human; D013831:Thiamine